(Press-News.org) CHICAGO – Among women with invasive epithelial ovarian cancer, patients having a germline (gene change in a reproductive cell that could be passed to offspring) mutation in the BRCA1 or BRCA2 genes was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to a study in the January 25 issue of JAMA.
"Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 are the strongest known genetic risk factors for both breast and epithelial ovarian cancer (EOC) and are found in 6 percent to 15 percent of women with EOC," according to background information in the article. "The relative prognosis of BRCA1/2 carriers and noncarriers is unclear."
Kelly L. Bolton, Ph.D., of the National Cancer Institute, Bethesda, Md., and colleagues conducted a study to provide evidence of the relative effect of germline BRCA1 and BRCA2 mutations on prognosis for women with epithelial ovarian cancer. The study consisted of a pooled analysis of 26 observational studies on the survival of women with ovarian cancer, which included data from 1,213 EOC cases with pathogenic germline mutations in BRCA1 (n = 909) or BRCA2 (n = 304) and from 2,666 noncarriers recruited and followed up at variable times between 1987 and 2010. During the 5 years following EOC diagnosis, 1,766 deaths occurred.
The researchers found that 5-year overall survival was 36 percent for noncarriers of the gene mutations, 44 percent for BRCA1 carriers, and 52 percent for BRCA2 carriers. In a model only adjusted for study site and year of diagnosis, BRCA1 carriers had a more favorable survival than noncarriers, which improved slightly after additional adjustment for stage, grade, histology, and age at diagnosis. BRCA2 carriers had a greater survival advantage compared with noncarriers, particularly after adjusting for other prognostic factors.
The survival advantage for BRCA1 and BRCA2 carriers compared with noncarriers was present but less marked among women who reported a family history of ovarian, breast cancer, or both.
"Our study results have potentially important implications for the clinical management of patients with EOC. Most immediately, our findings can be used by health care professionals for patient counseling regarding expected survival. BRCA1 and BRCA2 carriers with EOC respond better than noncarriers to platinum-based chemotherapies and have improved survival despite the fact that the disease is generally diagnosed at a later stage and higher grade. If patients could be stratified based on their BRCA status, their treatment could be tailored to reflect this, with noncarriers targeted for more aggressive treatments. Our data provide further support that there may be different functional mechanisms involved in the etiology of different subtypes of EOCs and, therefore, different therapeutic targets based on germline and somatic [changes to the genetics of a multicellular organism which are not passed on to its offspring through the germline] genetic variation," the researchers write.
"… given the important prognostic information provided by BRCAl and BRCA2 status and the potential for personalized treatment in carriers, the routine testing of women presenting with high-grade serous EOC may now be warranted."
(JAMA. 2012;307[4]:382-390. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
David M. Hyman, M.D., and David R. Spriggs, M.D., of Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, write in an accompanying editorial that the data from this study have important implications for the future of ovarian cancer research and treatment.
"Phase 3 studies that do not stratify by BRCA mutation status or account for this factor in a preplanned statistical analysis risk possible confounding because approximately 15 percent of unselected patients with serous ovarian cancer will carry germline BRCAl/2 mutations. Moreover, other studies have found differences in chemotherapy responsiveness and progression-free survival between sporadic BRCAl -and BRCA2-associated ovarian cancers. Germline BRCA testing needs to be consistently incorporated into both the routine management and future phase 3 trials of ovarian cancer."
(JAMA. 2012;307[4]:408-410. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
###
To contact corresponding author Paul D. P. Pharoah, Ph.D., email paul.pharoah@srl.cam.ac.uk; to contact Kelly L. Bolton, Ph.D., call the NCI Press Office at 301-496-6641 or email ncipressofficers@mail.nih.gov. To contact editorial co-author David R. Spriggs, M.D., call Courtney DeNicola Nowak at 212-639-3573 or email denicolc@mskcc.org.
END
CHICAGO – Elevated exposures in children to perfluorinated compounds, which are widely used in manufacturing and food packaging, were associated with lower antibody responses to routine childhood immunizations, according to a study in the January 25 issue of JAMA.
"Fluorine-substituted organic compounds have thousands of important industrial and manufacturing applications and occur widely in surfactants and repellants in food packaging and textile impregnation. The perfluorinated compounds (PFCs) are highly persistent and cause contamination of drinking water, food, ...
Boston, MA—A new study finds that perfluorinated compounds (PFCs), widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging, were associated with lowered immune response to vaccinations in children. It is the first study to document how PFCs, which can be transferred to children prenatally (via the mother) and postnatally from exposure in the environment, can adversely affect vaccine response.
The study appears in the January 25, 2012 issue of the Journal of the American Medical Association (JAMA).
"Routine childhood ...
Wetland restoration is a billion-dollar-a-year industry in the United States that aims to create ecosystems similar to those that disappeared over the past century. But a new analysis of restoration projects shows that restored wetlands seldom reach the quality of a natural wetland.
"Once you degrade a wetland, it doesn't recover its normal assemblage of plants or its rich stores of organic soil carbon, which both affect natural cycles of water and nutrients, for many years," said David Moreno-Mateos, a University of California, Berkeley, postdoctoral fellow. "Even after ...
TeamSupport.com (http://www.TeamSupport.com) - the popular provider of web-based customer support and help desk software solutions - today announced the release of a powerful new screen capture capability. It gives users the ability to record audio and video of a discrepancy and embed it in tickets submitted to a TeamSupport-enabled customer portal.
Available to users of both TeamSupport's basic and advanced ticket submission portals, the option offers an "Add Screen Recording" button below the description box when filling-out a new support request. Users ...
Asthma and gastroesophageal reflux (GER) are both common illnesses in children. GER in children often occurs without the typical symptoms of heartburn, and physicians frequently prescribe the acid reflux drug lansoprazole to supplement the standard inhaled steroid treatment for children with uncontrolled asthma regardless of GER symptoms. However, a randomized clinic trial conducted by the American Lung Association's Asthma Clinical Group found that the addition of lansoprazole does not improve asthma symptoms or the control of asthma in children and may increase the risk ...
A new method for identifying bacteria that cause urinary tract infections (UTIs) will lead to much faster, more effective treatment as well as a reduction in costs. The procedure, described in the Journal of Medical Microbiology, could eventually be used for the identification of micro-organisms in other bodily fluids, including blood and spinal fluid.
Scientists at the University Hospital Essen in Germany tested urine samples from in-house patients and were able to effectively separate and accurately identify bacteria using a technique called Matrix-Assisted Laser Desorption ...
Teaching children with autism to 'talk things through in their head' may help them to solve complex day-to-day tasks, which could increase the chances of independent, flexible living later in life, according to new research.
The study, led by Durham University, found that the mechanism for using 'inner speech' or 'talking things through in their head' is intact in children with autism but not always used in the same way as typically developing children do.
The psychologists found that the use, or lack of, thinking in words is strongly linked to the extent of someone's ...
The mating habits of marine turtle may help to protect them against the effects of climate change, according to new research led by the University of Exeter. Published today (25 January 2012) in the journal Proceedings of the Royal Society B, the study shows how the mating patterns of a population of endangered green turtles may be helping them deal with the fact that global warming is leading to a disproportionate number of females being born.
The gender of baby turtles is determined by the temperature of the eggs during incubation, with warmer temperatures leading to ...
New Jersey families continue to suffer through the greatest economic downturn since the Great Depression. Many unemployed workers still cannot find work and their debt only "snow-balls" - often to the point where it is impossible to get out from underneath it. For many of these struggling families, the only option they can turn to for assistance during these dire times is bankruptcy.
Often individuals consider bankruptcy as a response to mounting credit card debt. Generally, credit card debt is one of the largest unsecured debts held by most people filing for ...
Los Angeles, CA – Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
The new guidelines represent an expert consensus summary, and recommend a contemporary, standardized, and evidence-based approach to investigators conducting and reporting randomised, controlled migraine clinical trials.
Migraine clinical research has increased exponentially ...
